SEBI (Prohibition of Insider Trading) Regulations, 2015
The document, verbatim
Guidance Note on SEBI (Prohibition of Insider Trading) Regulations, 2015.
[August 24th, 2015]
SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the Regulations") were
notified vide notification dated 15th January, 2015. The regulations came into effect from
May 15th, 2015. Subsequently SEBI received certain queries from the market
participants seeking guidance on the interpretation of some provisions of the Regulations.
Under regulation 11 of the Regulations, SEBI may provide guidance to the market to
remove any difficulties in the interpretation or application of the provisions of these
regulations. The queries received and the guidance sought is detailed below for the
guidance of market participants:-
ESOPS:
1.
Does the contra trade restriction (for a period not less than six months) under
clause 10 of Schedule B of the Regulations also apply to the exercise of ESOPs and the
sale of shares so acquired?
Guidance: Exercise of ESOPs shall not be considered to be “trading” except for
thepurposes of Chapter III of the Regulations. However, other provisions of
theRegulations shall apply to the sale of shares so acquired.
For Example:
(i) If a designated person has sold/ purchased shares, he can subscribe and exercise
ESOPs at any time after such sale/purchase, without attracting contra trade restrictions.
(ii) Where a designated person acquires shares under an ESOP and subsequently
sells/pledges those shares, such sale shall not be considered as contra trade, with respect
to exercise of ESOPs.
(iii) Where a designated person purchases some shares (say on August 01, 2015),
acquires shares later under an ESOP (say on September 01, 2015) and subsequently
sells/pledges (say on October 01, 2015) shares so acquired under ESOP, the sale will not
be a contra trade but will be subject other provisions of the Regulations, however, he will
not be able to sell the shares purchased on August 01, 2015 during the period of six
months from August 01, 2015.
(iv) Where a designated person sells shares (say on August 01, 2015), acquires shares
later under an ESOP (say on September 01, 2015) the acquisition under ESOP shall not
be a contra trade. Further, he can sell/pledge shares so acquired at anytimethereafter
without attracting contra trade restrictions. He, however, will not be able to purchase
further shares during the period of six months from August 01, 2015 whenhe had sold
shares.
CONTRA TRADE:
2.
In case an employee or a director enters into Future & Option contract of
Near/Mid/Far month contract, on expiry will it tantamount to contra trade? If the scrip
of the company is part of any Index, does the exposure to that index of the employee or
director also needs to be reported?
Guidance: Any derivative contract that is cash settled on expiry shall be considered to be
a contra trade. Trading in index futures or such other derivatives where the scrip is part of
such derivatives, need not be reported.
3.
Whether contra trade is allowed within the duration of the trading plan?
Guidance: Any trading opted by a person under Trading Plan can be done only to the
extent and in the manner disclosed in the plan, save and except for pledging of securities
(Refer question 6).
4.
Whether the restriction on execution of contra trade in securities isapplicable in
case of buy back offers, open offers, rights issues FPOs etc by listedcompanies?
Guidance:Buy back offers, open offers, rights issues, FPOs, bonus, 1[exit offers]etc. of a
listed company are available to designated persons also, and restriction of ‘contra-trade’
shall not apply in respect of such matters.
5.
Whether restriction on execution of contra trade is applicable only todesignated
persons of a listed company or whether it would also apply to thedesignated employees
of market intermediaries and other persons who are requiredto handle UPSI in the
course of business operations?
Guidance: The code prescribed by the Regulations is same for listed companies, market
intermediaries and other persons who are required to handle UPSI in the course of
business operations. Therefore, restrictions with regard to contra trade forming part of
clause 10 of code of conduct shall apply to all according to the Regulations.
1 Inserted by Press note No. 77/2016 dated 12.04.2016w.e.f. 17.02.2016.
PLEDGE:
6.
(a) Whether SEBI's intent is to prohibit creation of pledge or invocation of
pledge for enforcement of security while in possession of UPSI?
(b)
Whether creation of pledge or invocation of pledge is allowed when trading
window is closed?
Guidance: Yes. However, the pledgor or pledgee may demonstrate that the creationof
pledge or invocation of pledge was bona fide and prove their innocence underproviso to
sub-regulation (1) of regulation 4 of the Regulations.
7.
What should be the value of the pledge / revoke transaction for the purpose of
disclosure? Is it the market value on date of the pledge / revoke transaction or is it the
value at which the transaction has been carried out between the pledgor and pledgee?
For instance, if the pledgor has availed a loan of Rs 10 Lacs against which he has
pledged shares worth Rs 15 Lacs, would the transaction value be Rs 10 Lacs or Rs 15
Lacs.
Guidance: For the purpose of calculation of threshold for disclosures relating topledge
under Chapter III of the Regulations, the market value on the date ofpledge/revoke
transaction should be considered. In the above illustration, the value oftransaction would
be considered as fifteen lakh rupees.
MISCELLANEOUS:
8.
Who will be approving authority for trades done by the Compliance Officer or
his immediate relatives, as Insiders?
Guidance: The board of directors of the company shall be the approving authority insuch
cases and may stipulate such procedures as are deemed necessary to ensurecompliance
with these regulations.
9.
Whether separate code of conduct can be adopted for listed company and each
of intermediaries in a group?
Guidance: In case of a group, separate code may be adopted for listed company andeach
of intermediaries, as applicable to the concerned entity.
10.
Whether Chief investor relations officer will also be responsible along with
compliance officer for not disseminating information or non-disclosure of UPSI?
Guidance: Regulation 2 (c) clearly provides the functions and responsibilities of
thecompliance officer. Specific responsibilities to deal with dissemination of
informationand disclosure of unpublished price sensitive information are given to Chief
InvestorRelations Officer (CIRO) under clause 3 of Schedule A.
It is company’s discretion to designate two separate persons as CIRO and
ComplianceOfficer, respectively for fulfilling specified responsibilities. In cases where
both CIRO and CO have been designated for overlapping functions, they shall be jointly
and severally responsible.
11.
If a spouse is financially independent and does not consult an insider while
taking trading decisions, is that spouse exempted from the definition of ‘immediate
relative’?
Guidance: A spouse is presumed to be an ‘immediate relative’, unless rebutted so.
*************